Similar articles

• [Determination of bacterial sensitivity to neggram from the aspect of its clinical use].

  Chernomordik AB. Chernomordik AB. Urol Nefrol (Mosk). 1971 Sep-Oct;36(5):63-5. Urol Nefrol (Mosk). 1971. PMID: 4946794 Russian. No abstract available.
• [Clinical experience with the use of oxolinic acid (Gramurin) and nalidixic acid (Nevigramon)].

  Kelenhegyi M, Szabó Z, Soltész I, Varga A. Kelenhegyi M, et al. Orv Hetil. 1978 Sep 10;119(37):2267-9. Orv Hetil. 1978. PMID: 358051 Clinical Trial. Hungarian. No abstract available.
• Nalidixic acid in urinary infection.

  Neogy KN, De MS, Chatterjee ML. Neogy KN, et al. Bull Calcutta Sch Trop Med. 1968 Jan;16(1):11-2. Bull Calcutta Sch Trop Med. 1968. PMID: 4890385 No abstract available.
• Review of bacterial resistance--a challenge to the treatment of urinary infection.

  Slack R. Slack R. J Antimicrob Chemother. 1984 May;13 Suppl B:1-7. doi: 10.1093/jac/13.suppl_b.1. J Antimicrob Chemother. 1984. PMID: 6376460 Review. No abstract available.
• Drug therapy reviews: oxolinic acid.

  Gleckman R, Alvarez S, Joubert DW, Matthews SJ. Gleckman R, et al. Am J Hosp Pharm. 1979 Aug;36(8):1077-9. Am J Hosp Pharm. 1979. PMID: 384788 Review. No abstract available.